NCT00801710 - CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

September 30, 2009

Conditions

Coronary Artery DiseaseCoronary Artery Chronic Total Occlusion

Interventions

DEVICE

BridgePoint Medical System (CrossBoss Catheter, Stingray Catheter, Entera Guidewire)

"Revascularization of coronary artery chronic total occlusion.~Use of the BridgePoint Medical System to cross coronary CTOs prior to definitive revascularization treatment via angioplasty and/or stent implant"

Trial Locations (4)

Unknown

Main Taunus Hospital, Bad Soden

Klinikum Darmstadt, Darmstadt

CardioVascular Center Frankfurt, St. Katharinen Hospital, Frankfurt

Universitäres Herz- und Gefässzentrum Hamburg, Hamburg